1. Home
  2. DMRA vs ICHR Comparison

DMRA vs ICHR Comparison

Compare DMRA & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Damora Therapeutics Inc. Common Stock

DMRA

Damora Therapeutics Inc. Common Stock

SELL

Current Price

$22.10

Market Cap

1.4B

Sector

Health Care

ML Signal

SELL

Logo Ichor Holdings

ICHR

Ichor Holdings

SELL

Current Price

$33.00

Market Cap

1.4B

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
DMRA
ICHR
Founded
2011
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
DMRA
ICHR
Price
$22.10
$33.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
8
Target Price
$46.78
★ $67.88
AVG Volume (30 Days)
478.7K
★ 1.0M
Earning Date
11-04-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 121.48
N/A
EPS
N/A
★ 0.53
Revenue
N/A
★ $947,652,000.00
Revenue This Year
N/A
$30.28
Revenue Next Year
N/A
$32.00
P/E Ratio
★ N/A
$63.49
Revenue Growth
N/A
★ 11.61
52 Week Low
$16.50
$14.20
52 Week High
$34.89
$113.58

Technical Indicators

Market Signals
Indicator
DMRA
ICHR
Relative Strength Index (RSI) 49.17 36.48
Support Level $18.03 $27.73
Resistance Level $22.27 $53.95
Average True Range (ATR) 1.83 2.89
MACD 0.03 0.55
Stochastic Oscillator 30.13 33.08

Price Performance

Historical Comparison
DMRA
ICHR

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

About ICHR Ichor Holdings

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.

Share on Social Networks: